BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2409917)

  • 1. Interferon inducibility in mice treated with Corynebacterium parvum.
    Storch E; Kirchner H
    Antiviral Res; 1985 Apr; 5(2):117-23. PubMed ID: 2409917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of survival of mice bearing the Eb and ESb lymphoma by treatment with interferon inducers alone or in combination with Corynebacterium parvum.
    Storch E; Kirchner H; Schirrmacher V
    Cancer Immunol Immunother; 1986; 23(3):179-84. PubMed ID: 2431778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Corynebacterium acnes on interferon production in mouse peritoneal exudate cells.
    Fischbach J; Glasgow LA
    Infect Immun; 1975 Jan; 11(1):80-5. PubMed ID: 234914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Corynebacterium acnes on interferon production in mice.
    Farber PA; Glasgow LA
    Infect Immun; 1972 Sep; 6(3):272-6. PubMed ID: 4564888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attempts to correlate interferon induction and activation of natural killer cells by Corynebacterium parvum.
    Chmielarczyk W; Kirchner H; Ernst R; Storch E
    Immunobiology; 1985 May; 169(4):403-11. PubMed ID: 2408996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon production in Propionibacterium acnes treated mice.
    Cembrzyńska-Nowak M; Jarońska E; Zgórniak-Nowosielska I
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):217-24. PubMed ID: 2431669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antiviral properties of Corynebacterium parvum].
    Cerutti I
    C R Acad Hebd Seances Acad Sci D; 1974 Sep; 279(11):963-6. PubMed ID: 4376977
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice.
    Kirchner H; Chmielarczyk W; Storch E; Schindler L
    Behring Inst Mitt; 1984 May; (74):183-8. PubMed ID: 6206840
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection of mice against mouse hepatitis virus by Corynebacterium parvum.
    Schindler L; Streissle G; Kirchner H
    Infect Immun; 1981 Jun; 32(3):1128-31. PubMed ID: 6166566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interferon, antibodies and macrophages in the protective effect of Corynebacterium parvum on encephalomyocarditis virus-induced disease in mice.
    Géniteau-Legendre M; Forestier F; Quéro AM; German A
    Antiviral Res; 1987 Mar; 7(3):161-7. PubMed ID: 2440381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local interferon induction by bacterial lipopolysaccharide in mice after pretreatment with Corynebacterium parvum.
    Kirchner H; Weyland A; Storch E
    J Interferon Res; 1986 Oct; 6(5):483-7. PubMed ID: 3805784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages.
    Neumann C; Macher E; Sorg C
    Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of interferons produced by peripheral blood mononuclear cells from healthy subjects in response to Corynebacterium parvum or poly I: poly C.
    Hertzog PJ; Cheetham BF; Sexton JL; Linnane AW
    Biochem Int; 1989 Dec; 19(6):1427-36. PubMed ID: 2483976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interferon production in mouse spleen cell cultures by corynebacterium parvum.
    Hirt HM; Becker H; Kirchner H
    Cell Immunol; 1978 Jun; 38(1):168-75. PubMed ID: 307432
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon production and lymphocyte stimulation in human leucocyte cultures stimulated by Corynebacterium parvum.
    Hirt HM; Schwenteck M; Becker H; Kirchner H
    Clin Exp Immunol; 1978 Jun; 32(3):471-6. PubMed ID: 688696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent macrophage stimulation by Corynebacterium parvum.
    Loose LD; Astry CL; Megirian R
    J Immunopharmacol; 1980; 2(3):349-65. PubMed ID: 6821558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Corynebacterium parvum on human T-lymphocyte interferon production and T-lymphocyte proliferation in vitro.
    Sugiyama M; Epstein LB
    Cancer Res; 1978 Dec; 38(12):4467-73. PubMed ID: 309789
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    Cohen DA; Bubel HC
    J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effect of Corynebacterium parvum and poly ICLC on experimental brain tumors].
    Kiya K; Kitaoka T; Okamoto H; Harada K; Uozumi T; Toge T; Hattori T; Machida H
    Neurol Med Chir (Tokyo); 1983 Nov; 23(11):841-8. PubMed ID: 6201759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.